Prevalence of Metabolic Syndrome and Its Association with Cardiovascular Outcomes in Hospitalized Patients with Inflammatory Bowel Disease

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Nov 27

PMID 39598052

Authors

Ryan Njeim

Sai Shanmukha Sreeram Pannala

Nadim Zaidan

Toni Habib

Medha Rajamanuri

Elie Moussa

Liliane Deeb

Suzanne El-Sayegh

Affiliations

Soon will be listed here.

Abstract

: Patients with autoimmune diseases experience a higher burden of metabolic syndrome (MetS) and cardiovascular disease (CVD). There is a paucity of data regarding MetS in patients with inflammatory bowel disease (IBD) and its impact on CVD. In this retrospective study, we aimed to evaluate the prevalence of MetS components in IBD patients, as well as their association with acute coronary syndrome (ACS), heart failure and arrhythmias. : After pooling 5 years of data from the National Inpatient Sample (NIS) Database (2016-2020), we compared traditional cardiovascular risk factors between IBD and non-IBD patients. We then investigated the association between MetS (represented by a calculated metabolic score (CMS) ranging from 0 to 4, based on the presence or absence of hypertension, obesity, dyslipidemia and type II diabetes) and CVD, separately for Crohn's disease (CD) and ulcerative colitis (UC) patients. : The prevalence of the different MetS components was found to be lower in IBD patients compared to non-IBD patients. Comparing CD (n = 806,875) and UC (n = 575,925) identified a higher prevalence of MetS components in UC. Higher CMS was positively associated with ACS and arrhythmias in both CD and UC. This association was evident in heart failure, with the odds ratio increasing from 2.601 for CMS = 1 to 6.290 for CMS = 4 in UC patients and from 2.622 to 5.709 in CD patients. : Our study highlights the positive association between traditional components of MetS and CVD in IBD patients. Our findings suggest that chronic inflammation explains only partially the CVD burden in hospitalized IBD patients.

References

Gill G, Fernandez S, Malhotra N, Mete M, Garcia-Garcia H . Major acute cardiovascular events in patients with inflammatory bowel disease. Coron Artery Dis. 2020; 32(1):73-77. DOI: 10.1097/MCA.0000000000000899. View

Eriksson C, Sun J, Bryder M, Broms G, Everhov A, Forss A . Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Aliment Pharmacol Ther. 2024; 59(9):1122-1133. DOI: 10.1111/apt.17932. View

Mottillo S, Filion K, Genest J, Joseph L, Pilote L, Poirier P . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14):1113-32. DOI: 10.1016/j.jacc.2010.05.034. View

Moore L, Gaffney K, Lopez R, Shen B . Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study. Inflamm Bowel Dis. 2011; 18(4):743-9. DOI: 10.1002/ibd.21796. View

El Hadad J, Schreiner P, Vavricka S, Greuter T . The Genetics of Inflammatory Bowel Disease. Mol Diagn Ther. 2023; 28(1):27-35. PMC: 10787003. DOI: 10.1007/s40291-023-00678-7. View

Zamani M, Alizadeh-Tabari S, Singh S, Loomba R . Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2022; 55(8):894-907. PMC: 9297733. DOI: 10.1111/apt.16879. View

Huang P . A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6):231-7. PMC: 2675814. DOI: 10.1242/dmm.001180. View

Liu Z, Tang H, Liang H, Bai X, Zhang H, Yang H . Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China. Nutrients. 2022; 14(15). PMC: 9330762. DOI: 10.3390/nu14153040. View

Panhwar M, Mansoor E, Al-Kindi S, Sinh P, Katz J, Oliveira G . Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study. Inflamm Bowel Dis. 2018; 25(6):1080-1087. DOI: 10.1093/ibd/izy354. View

10.

Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K . High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J. 2007; 71(2):252-5. DOI: 10.1253/circj.71.252. View

11.

Fiorino G, Omodei P . Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?. J Crohns Colitis. 2015; 9(9):697-8. DOI: 10.1093/ecco-jcc/jjv110. View

12.

Pai U, Prabhu M, Devasia D, Rao D, V R, Samanth J . Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality. Indian Heart J. 2023; 75(6):462-464. PMC: 10774609. DOI: 10.1016/j.ihj.2023.10.006. View

13.

Ingelsson E, Arnlov J, Lind L, Sundstrom J . Metabolic syndrome and risk for heart failure in middle-aged men. Heart. 2006; 92(10):1409-13. PMC: 1861065. DOI: 10.1136/hrt.2006.089011. View

14.

Medina G, Vera-Lastra O, Peralta-Amaro A, Jimenez-Arellano M, Saavedra M, Cruz-Dominguez M . Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res. 2018; 133:277-288. DOI: 10.1016/j.phrs.2018.01.009. View

15.

. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019; 5(1):17-30. PMC: 7026709. DOI: 10.1016/S2468-1253(19)30333-4. View

16.

Flasar M, Johnson T, Roghmann M, Cross R . Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2007; 14(1):13-9. DOI: 10.1002/ibd.20298. View

17.

Villanacci V, Reggiani-Bonetti L, Salviato T, Leoncini G, Cadei M, Albarello L . Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica. 2021; 113(1):39-53. PMC: 8138698. DOI: 10.32074/1591-951X-235. View

18.

Lee M, Wang Y, Li Y, Tsai C, Chen S, Jhuang W . QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype. Int J Gen Med. 2022; 15:6189-6198. PMC: 9296885. DOI: 10.2147/IJGM.S361705. View

19.

Nagahori M, Hyun S, Totsuka T, Okamoto R, Kuwahara E, Takebayashi T . Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol. 2010; 45(10):1008-13. DOI: 10.1007/s00535-010-0247-z. View

20.

Gabbiadini R, Dal Buono A, Mastrorocco E, Solitano V, Repici A, Spinelli A . Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the of the issue. Front Cardiovasc Med. 2023; 10:1143293. PMC: 10227624. DOI: 10.3389/fcvm.2023.1143293. View